Funded Tech Companies
Allarity Therapeutics
Wondering who invested in Allarity Therapeutics? Streeterville Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Allarity Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
123 E Tarpon Ave
Tarpon Springs, FL 34689
USA
Tarpon Springs, FL 34689
USA
Phone
Website
Email Address
Company Background Information
Overview
Allarity Therapeutics is a late clinical-stage, precision medicine company actively advancing stenoparib for the treatment of advanced, recurrent ovarian cancer. At Allarity we leverage our proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Our DRP® technology has been broadly validated across an extensive array of therapies and tumor types with a high degree of accuracy for matching the right patient to the right drug. By identifying those patients who will and who will not respond, the DRP® companion diagnostics have the potential to transform cancer therapeutic development across many indications by increasing clinical success rates with trials involving a fewer number of patients, and improve patient outcomes by matching them to the right drug. Publicly traded on NASDAQ, Allarity Therapeutics (ALLR). Allarity Therapeutics (ALLR) is headquartered in Boston, MA, while maintaining an R&D facility in Hoersho
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/6/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Jensen
Chief Financial Officer
Jeff Ervin
Chief Scientific Officer
Steen Knudsen
President
Jeremy Graff
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs